Host: |
Rabbit |
Applications: |
WB/ELISA |
Reactivity: |
Human/Mouse/Rat |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
PBS with 0.09% Sodium Azide, 50% Glycerol, pH 7.3. |
Purification: |
Affinity purification |
Concentration: |
Lot specific |
Dilution Range: |
WB:1:500-1:1000ELISA:Recommended starting concentration is 1 Mu g/mL. Please optimize the concentration based on your specific assay requirements. |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
KLF9 |
Gene ID: |
687 |
Uniprot ID: |
KLF9_HUMAN |
Immunogen Region: |
1-150 |
Specificity: |
Recombinant fusion protein containing a sequence corresponding to amino acids 1-150 of human KLF9 (NP_001197.1). |
Immunogen Sequence: |
MSAAAYMDFVAAQCLVSISN RAAVPEHGVAPDAERLRLPE REVTKEHGDPGDTWKDYCTL VTIAKSLLDLNKYRPIQTPS VCSDSLESPDEDMGSDSDVT TESGSSPSHSPEERQDPGSA PSPLSLLHPGVAAKGKHASE KRHKCPYSGC |
Tissue Specificity | Epidermis (at protein level). |
Function | Transcription factor that binds to GC box promoter elements. Selectively activates mRNA synthesis from genes containing tandem repeats of GC boxes but represses genes with a single GC box. Acts as an epidermal circadian transcription factor regulating keratinocyte proliferation. |
Protein Name | Krueppel-Like Factor 9Basic Transcription Element-Binding Protein 1Bte-Binding Protein 1Gc-Box-Binding Protein 1Transcription Factor Bteb1 |
Cellular Localisation | Nucleus |
Alternative Antibody Names | Anti-Krueppel-Like Factor 9 antibodyAnti-Basic Transcription Element-Binding Protein 1 antibodyAnti-Bte-Binding Protein 1 antibodyAnti-Gc-Box-Binding Protein 1 antibodyAnti-Transcription Factor Bteb1 antibodyAnti-KLF9 antibodyAnti-BTEB antibodyAnti-BTEB1 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance